First steps for the development of silk fibroin-based 3D biohybrid retina for age-related macular degeneration (AMD).
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32947273.
- Also identified by DOI 10.1088/1741-2552/abb9c0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Age-related macular degeneration is an incurable chronic neurodegenerative disease, causing progressive loss of the central vision and even blindness. Up-to-date therapeutic approaches can only slow down he progression of the disease. Feasibility study for a multilayered, silk fibroin-based, 3D biohybrid retina. Fabrication of silk fibroin-based biofilms; culture of different types of cells: retinal pigment epithelium, retinal neurons, Müller and mesenchymal stem cells ; creation of a layered structure glued with silk fibroin hydrogel. In vitro evidence for the feasibility of layered 3D biohybrid retinas; primary culture neurons grow and develop neurites on silk fibroin biofilms, either alone or in presence of other cells cultivated on the same biomaterial; cell organization and cellular phenotypes are maintained in vitro for the seven days of the experiment. 3D biohybrid retina can be built using silk silkworm fibroin films and hydrogels to be used in cell replacement therapy for AMD and similar retinal neurodegenerative diseases.
Medical subject headings
- Fibroins
- Macular Degeneration
- Neurodegenerative Diseases